Serial intravascular ultrasound analysis of the impact of lesion length on the efficacy of intracoronary gamma-irradiation for preventing recurrent in-stent restenosis

Circulation. 2001 Jan 16;103(2):188-91. doi: 10.1161/01.cir.103.2.188.

Abstract

Background: The relation between lesion length and effectiveness of brachytherapy is not well studied.

Methods and results: We compared serial (postintervention and follow-up) intravascular ultrasound findings in 66 patients with native coronary artery in-stent restenosis (ISR) who were treated with (192)Ir (15 Gy delivered 2 mm away from the radiation source). Patients were enrolled in the Washington Radiation for In-Stent Restenosis Trial (WRIST; ISR length, 10 to 47 mm; n=36) or Long WRIST (ISR length, 36 to 80 mm; n=30). External elastic membrane, stent, lumen, and intimal hyperplasia (IH; stent minus lumen) areas and source-to-target (intravascular ultrasound catheter to external elastic membrane) distances were measured. Postintervention stent areas were larger in WRIST and smaller in Long WRIST patients (P:<0.0001). At follow-up, maximum IH area significantly increased in both WRIST and Long WRIST patients (P:<0.0001 for both), but this increase was greater in Long WRIST patients (P:=0.0006). Similarly, minimum lumen cross-sectional area significantly decreased in both WRIST and Long WRIST patients (P:<0.05 and P:<0.0001, respectively), but this decrease was more pronounced in Long WRIST patients (P:=0.0567). The maximum source-to-target distance was longer in Long WRIST than in WRIST, and it correlated directly with ISR length (r=0.547, P:<0.0001). Overall, the change in minimum lumen area and the change in maximum IH area correlated with the maximum source-to-target distance (r=0.352, P:=0.0038 and r=0.523, P:<0.0001 for WRIST and Long WRIST, respectively). The variability (maximum/minimum) in IH area at follow-up also correlated with the maximum source-to-target distance (r=0.378, P:<0.0001).

Conclusions: Brachytherapy may be less effective in longer ISR lesions because of the greater variability and longer source-to-target distances in diffuse ISR.

Publication types

  • Clinical Trial

MeSH terms

  • Brachytherapy* / standards
  • Coronary Restenosis / prevention & control
  • Coronary Stenosis / diagnostic imaging*
  • Coronary Stenosis / prevention & control
  • Coronary Stenosis / radiotherapy*
  • Coronary Vessels / diagnostic imaging
  • Follow-Up Studies
  • Gamma Rays / therapeutic use*
  • Humans
  • Hyperplasia
  • Iridium Radioisotopes / therapeutic use
  • Randomized Controlled Trials as Topic
  • Stents*
  • Treatment Outcome
  • Tunica Intima / diagnostic imaging
  • Ultrasonography, Interventional* / methods

Substances

  • Iridium Radioisotopes